Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | ACE | P12821 | 6/20 | 0.31 |
| ▸ | REN | P00797 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PEPD | P12955 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5940292 | 1.00 | POLB (0.31) | POLBL3MBTL1CHRM2CHRM1ACE | |
| SCHEMBL5117331 | 0.79 | POLB (0.39) | POLBL3MBTL1ACERENKDM4E | |
| SCHEMBL5117334 | 0.79 | POLB (0.39) | POLBL3MBTL1ACERENKDM4E | |
| SCHEMBL5939979 | 0.77 | PREP (0.57) | F2HSD17B10ACE2PREP | |
| SCHEMBL5939985 | 0.77 | PREP (0.57) | F2HSD17B10ACE2PREP | |
| SCHEMBL3340426 | 0.73 | POLB (0.41) | POLBL3MBTL1ACERENKDM4E | |
| SCHEMBL474931 | 0.73 | POLB (0.41) | POLBL3MBTL1ACERENKDM4E | |
| SCHEMBL4936887 | 0.73 | POLB (0.41) | POLBL3MBTL1ACERENKDM4E | |
| SCHEMBL3596371 | 0.72 | ACE (0.36) | POLBL3MBTL1ACERENKDM4E | |
| SCHEMBL3596373 | 0.72 | ACE (0.36) | POLBL3MBTL1ACERENKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060178359-A1 | Tricyclic compound, process for producing the same, and use | SYNGENTA CROP PROTECTION AG (CH) | 2006-08-10 | — | — | US | disclosed |
| EP-1593681-A1 | TRICYCLIC COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE | Takeda Pharmaceutical Company Limited (JP) | 2005-11-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178359-A1 | Tricyclic compound, process for producing the same, and use | CCR4, CCR5, CCR1 | POLB 1406/4885L3MBTL1 1758/4885CHRM2 64/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.